<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01427140</url>
  </required_header>
  <id_info>
    <org_study_id>SLS-2011-LPG</org_study_id>
    <nct_id>NCT01427140</nct_id>
  </id_info>
  <brief_title>Metabolic Consequences of Moderate Weight Gain - Role of Dietary Fat Composition (LIPOGAIN)</brief_title>
  <acronym>LIPOGAIN</acronym>
  <official_title>Metabolic Consequences of Moderate Weight Gain - Role of Dietary Fat Composition (LIPOGAIN): a Randomized Double-Blind Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the metabolic consequences of a moderate weight
      gain and if the type of dietary fat (saturated versus polyunsaturated) can modify the effects
      in young healthy adults. Hypothesis: the type of dietary fat can modify the effects of weight
      gain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific goals:

        -  Investigate if dietary fat composition influences liver fat accumulation and metabolic
           risk factors in response to moderate weight gain

        -  Investigate if polyunsaturated fat (PUFA) in the diet could counteract any unfavorable
           metabolic changes that are expected to accompany moderate weight gain

        -  Investigate effects of weight gain and dietary fat composition on markers of vascular
           health
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic steatosis by magnetic resonance tomography (MRT)</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>high density lipoprotein (HDL)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>low density lipoprotein (LDL)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein B (ApoB)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apolipoprotein A1 (ApoA1)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aspartate aminotransferase (ASAT)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alanine aminotransferase (ALAT)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gamma glutamyl transpeptidase (GGT)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Homeostasis model of assessment insulin resistance (HOMA-IR)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein (CRP)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proinsulin</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endostatin</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pentraxin-3 (PTX-3)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelin-1 (ET-1)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E-selectin</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cathepsin-S</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cystatin C</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Saturated fatty acid group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Addition of saturated fatty acids to the diet inte the form of pastries</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Polyunsaturated fatty acid group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Addition of polyunsaturated fatty acids to the diet in the form of pastries</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Polyunsaturated fatty acid group</intervention_name>
    <description>Addition of polyunsaturated fatty acids to the diet in the form of pastries</description>
    <arm_group_label>Polyunsaturated fatty acid group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saturated fatty acid group</intervention_name>
    <description>Addition of saturated fatty acids to the diet in the form of pastries</description>
    <arm_group_label>Saturated fatty acid group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy,

          -  Body Mass Index 18-27

        Exclusion Criteria:

          -  Liver disease,

          -  Coronary heart disease,

          -  Diabetes mellitus,

          -  Malignant diseases,

          -  Alcohol or drug abuse,

          -  Magnetic Resonance-incompatibility,

          -  Abnormal clinical chemistry,

          -  Use of drugs that significantly effects energy metabolism,

          -  Heavy exercise,

          -  Pregnancy or lactation,

          -  Allergy of gluten, egg or milk protein
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf Ris√©rus, Ass. professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Nutrition and Metabolism, Dept. of Public Health and Caring Sciences, Uppsala University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uppsala University Hospital, Uppsala Science Park</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2011</study_first_submitted>
  <study_first_submitted_qc>August 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2011</study_first_posted>
  <last_update_submitted>December 8, 2011</last_update_submitted>
  <last_update_submitted_qc>December 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liver fat</keyword>
  <keyword>Polyunsaturated fatty acids (PUFA)</keyword>
  <keyword>Saturated fatty acids (SFA)</keyword>
  <keyword>Weight gain</keyword>
  <keyword>Overfeed</keyword>
  <keyword>Dietary fatty acids</keyword>
  <keyword>Palm oil</keyword>
  <keyword>Sunflower oil</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Weight Gain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

